Kirk Ways Spruce Biosciences, Inc. (SPRB) insider trading activity
Kirk Ways is Interim Chief Medical Officer of SPRUCE BIOSCIENCES, INC.. Currently has a direct ownership of 1,250 shares of SPRB, which is worth approximately $132,925. The most recent transaction as insider was on Dec 11, 2025, when has been sold 1,250 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).
Shares Held (Direct Ownership)
1.25K
n/a
3M change
n/a
12M change
Total Value Held
$132,925
KW
Kirk Ways
Interim Chief Medical Officer
Daly City, CA